A commercial-stage biotechnology company developing tumor-infiltrating lymphocyte (TIL) therapies for cancer, an approach that uses a patient’s own immune cells to target tumors. Iovance Holdings focuses on cell therapies for solid tumors, including lifileucel for advanced melanoma, and is building ...
1 member of Congress has disclosed 1 trade in Iovance Holdings Inc (IOVA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-09-11 | Greg Gianforte | sell | $1K – $15K |